Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGER2 | P43116 | 5/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.32 |
| ▸ | PTGER4 | P35408 | 1/20 | 0.32 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9976696 | 1.00 | PTGER2 (0.33) | PTGER2ALDH1A1LMNATBXA2RPTGER4 | |
| SCHEMBL12088009 | 0.84 | PTGER2 (0.35) | PTGER2ALDH1A1LMNATBXA2RPTGER4 | |
| SCHEMBL2738742 | 0.83 | PTGER2 (0.38) | PTGER2ALDH1A1LMNATBXA2RPTGER4 | |
| SCHEMBL2738741 | 0.83 | PTGER2 (0.38) | PTGER2ALDH1A1LMNATBXA2RPTGER4 | |
| SCHEMBL14098097 | 0.83 | PTGER2 (0.38) | PTGER2ALDH1A1LMNATBXA2RPTGER4 | |
| SCHEMBL16504095 | 0.83 | PTGER2 (0.38) | PTGER2ALDH1A1LMNATBXA2RPTGER4 | |
| SCHEMBL10020798 | 0.83 | PTGER2 (0.38) | PTGER2ALDH1A1LMNATBXA2RPTGER4 | |
| SCHEMBL861931 | 0.83 | PTGER2 (0.38) | PTGER2ALDH1A1LMNATBXA2RPTGER4 | |
| SCHEMBL2738740 | 0.82 | PTGER2 (0.33) | PTGER2ALDH1A1LMNATBXA2RPTGER4 | |
| SCHEMBL16504092 | 0.82 | PTGER2 (0.33) | PTGER2ALDH1A1LMNATBXA2RPTGER4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8143316-B2 | Method for treating peripheral vascular diseases | SUCAMPO AG (CH) | 2012-03-27 | — | — | US | disclosed |